Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes Victor M. LuKrishnan RavindranMichael J. Link Topic Review 28 June 2019 Pages: 239 - 248
Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know? Charissa A. C. JessurunAlexander F. C. HulsbergenMarike L. D. Broekman Topic Review Open access 25 July 2019 Pages: 249 - 264
Absent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme P. A. ChenG. ShrivastavaChristopher Power Laboratory Investigation 06 July 2019 Pages: 265 - 273
Comparison of ABC/2 estimation and a volumetric computerized method for measurement of meningiomas using magnetic resonance imaging Charles F. OpalakMatthew ParryWilliam C. Broaddus Clinical Study 10 August 2019 Pages: 275 - 282
Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping Tejpal GuptaMadan MaitreAliasgar Moiyadi Clinical Study 24 June 2019 Pages: 283 - 291
MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma Yi ChaiCaixia WangYuqi Zhang Clinical Study 24 June 2019 Pages: 293 - 301
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II) John D. HainsworthKevin P. BeckerKent Shih Clinical Study 07 August 2019 Pages: 303 - 311
Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery Philip C. De Witt HamerVincent K. Y. Hoon behalf of the Quality Registry Neuro Surgery glioblastoma working group from the Dutch Society of Neurosurgery Clinical Study Open access 24 June 2019 Pages: 313 - 323
Single-fraction stereotactic radiosurgery for spindle cell oncocytoma: preliminary experience and systematic review of the literature Soliman OushyChristopher S. GraffeoBruce E. Pollock Clinical Study 28 June 2019 Pages: 325 - 332
Analysis of patterns of failure and appraisal of postoperative radiation field for grade II–III meningioma Jason Joon Bock LeeJeongshim LeeChang-Ok Suh Clinical Study 05 July 2019 Pages: 333 - 341
Fractionated stereotactic radiotherapy for local control of resected brain metastases Jeffrey I. TraylorAhmed HabibGanesh Rao Clinical Study 16 July 2019 Pages: 343 - 350
A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer Chengcheng GuiNamrata ChintalapatiKristin Janson Redmond Clinical Study 13 July 2019 Pages: 351 - 358
Phase II study of Dovitinib in recurrent glioblastoma Mayur SharmaCathy SchileroManmeet S. Ahluwalia Clinical Study 11 July 2019 Pages: 359 - 368
Treatment of dedifferentiated chordoma: a retrospective study from a large volume cancer center Ryan N. NachwalterRobert J. RothrockDaniel S. Higginson Clinical Study 23 July 2019 Pages: 369 - 376
Multidimensional assessment of fatigue in patients with brain metastases before and after Gamma Knife radiosurgery Eline VerhaakWietske C. M. SchimmelKarin Gehring Clinical Study Open access 26 July 2019 Pages: 377 - 384
Cysts associated with intramedullary ependymomas of the spinal cord: clinical, MRI and oncological features Corentin DauleacRostom MessererCédric Y. Barrey Clinical Study 23 July 2019 Pages: 385 - 391
Stereotactic radiosurgery in elderly patients with brain metastases: comparison with non-elderly patients using database of a multi-institutional prospective observational study (JLGK0901-Elderly) Yoshinori HiguchiMasaaki YamamotoHidefumi Aoyama Clinical Study 23 July 2019 Pages: 393 - 402
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma Thomas J. KaleyKatherine S. PanageasAndrew B. Lassman Clinical Study 19 July 2019 Pages: 403 - 407
Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective study Eike SteidlMathias MüllerElke Hattingen Clinical Study 18 July 2019 Pages: 409 - 417
Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study M. C. MorisseN. Etienne-SelloumB. Chauffert Clinical Study 19 July 2019 Pages: 419 - 426
Correction to: Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes Abdurrahman I. IslimMidhun MohanMichael D. Jenkinson Correction Open access 31 July 2019 Pages: 427 - 429
Retraction Note to: Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis Yoshihiro SatoYoshiaki HondaEiichiro Honda Retraction Note 29 July 2019 Pages: 431 - 431